期刊文献+

醛固酮受体拮抗剂的降压治疗进展 被引量:3

Advances in Aldosterone Receptor Antagonists on Hypertension
下载PDF
导出
摘要 醛固酮是肾素-血管紧张素-醛固酮系统的终末环节,在原发性高血压、顽固性高血压中起重要作用。醛固酮受体拮抗剂在高血压治疗方面的作用越来越受到重视。现综述醛固酮在高血压中的病理生理作用,醛固酮受体拮抗剂的分类、降压机制及临床应用进展等。 The hormone aldosterone is the final product of the renin angiotensin aldosterone system,which contributes significantly to primary and sustained hypertension.Increasingly attention is being given to the role aldosterone has in influencing blood pressure.This review shows the pathophysiology of aldosterone,its classification and mechanism,and clinical uses of aldosterone receptor antagonist.
出处 《心血管病学进展》 CAS 2011年第4期565-568,共4页 Advances in Cardiovascular Diseases
关键词 醛固酮 醛固酮受体拮抗剂 高血压 治疗 aldosterone aldosterone receptor antagonist hypertension treatment
  • 相关文献

参考文献31

  • 1Vasan RS, Evans JC, Larson MG, et al. Serum aldosterone and the incidence of hypertension in nonhypertensive persons[J]. N Engl J Med,2004,351 ( 1 ) : 33-41.
  • 2Sehlaich MP, Klingbeil AU, Jacobi J, et al. Altered aldosterone response to salt intake and angiotensin Ⅱ infusion in young normotensive men with parental history of arterial hypertension[J]. Hypertension,2002,20(1) :117-124.
  • 3Pimenta E, Calhoun DA. Resistant hypertension and aldosteronism [ J]. Curr Hypertens Rep,2007,9(5) :353-359.
  • 4Jansen PM, Boomsma F, van den Meiraeker AH. Aldosterone-to-renin ratio as a screening test for primary aldosteronism: the Dutch ARRAT Study [ J ]. Neth Med,2008,66( 5 ) :220-228.
  • 5Calhoun DA, Jones D, Textor S, et al. Resistant hypertension : diagnosis, evaluation, and treatment. A scientific statement from the American Heart Associa- tion Professional Education Committee of the Council for High Blood Pressure Research[J]. Hypertension,2008,51 (6) :1403-1419.
  • 6Gaddam KK, Nishisaka MK, Pratt-Ubunama MN, et al. Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion [ J ]. Arch Intern Med,2008,168 (11) :1159-1164.
  • 7Sartori M, Calo LA, Mascagna V, et al. Aldosterone and refractory hyperten- sion: a prospective cohort study[J]. Hypertension,2006,19(4) :373-379.
  • 8Bomback AS, Klemmer PJ. The incidence and implications of aldosterone breakthrough[J]. Nat Clin Pract Nephrol,2007, 3(9) :486-492.
  • 9Young MJ. Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation [ J ]. Curr Opin Nephrol Hypertens, 2008,17 ( 2 ) : 174-180.
  • 10Catena C, Colussi G, Nadalini E, et al. Cardiovascular outcomes in patients with primary aldasteronism after treatment [ J ]. Arch Intern Med, 2008,168 ( 1 ) :80-85.

同被引文献52

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部